These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2443540

  • 1. Defective antigen presentation and novel structural properties of DR1 from an HLA haplotype associated with 21-hydroxylase deficiency.
    Davis JE, Rich RR, Van M, Le HV, Pollack MS, Cook RG.
    J Clin Invest; 1987 Oct; 80(4):998-1008. PubMed ID: 2443540
    [Abstract] [Full Text] [Related]

  • 2. Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14,DR1.
    Speiser PW, New MI, White PC.
    N Engl J Med; 1988 Jul 07; 319(1):19-23. PubMed ID: 3260007
    [Abstract] [Full Text] [Related]

  • 3. Polymorphic Bgl II restriction sites of DR alpha demarcate a novel HLA-DR1 antigen.
    Davis JE, Cook RG, Van M, Rich RR.
    Immunogenetics; 1988 Jul 07; 28(3):171-81. PubMed ID: 2900810
    [Abstract] [Full Text] [Related]

  • 4. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X, Bavari S, Ulrich R, Sadegh-Nasseri S, Ferrone S, McHugh L, Mage M.
    Eur J Immunol; 1997 Aug 07; 27(8):1933-41. PubMed ID: 9295029
    [Abstract] [Full Text] [Related]

  • 5. Late-onset form of congenital adrenal hyperplasia in the HLA-B14; DR1 haplotype is caused by a duplication in the 21-OH MHC gene region.
    Boehm BO, Rosak C, Kuehnl P, Schöffling K.
    Horm Metab Res; 1986 Nov 07; 18(11):791-2. PubMed ID: 3491779
    [No Abstract] [Full Text] [Related]

  • 6. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW, Flomenberg N, Horibe K, Winchester R, Radka SF, Dupont B.
    J Immunol; 1986 Oct 15; 137(8):2618-26. PubMed ID: 2428870
    [Abstract] [Full Text] [Related]

  • 7. HLA linkage and B14, DR1, BfS haplotype association with the genes for late onset and cryptic 21-hydroxylase deficiency.
    Pollack MS, Levine LS, O'Neill GJ, Pang S, Lorenzen F, Kohn B, Rondanini GF, Chiumello G, New MI, Dupont B.
    Am J Hum Genet; 1981 Jul 15; 33(4):540-50. PubMed ID: 6789674
    [Abstract] [Full Text] [Related]

  • 8. A division of HLA-DQw1 associated with DR1, DR1x-DQw1, DR2 short, DRw10, and DRw14. I. Definition by alloantiserum LY 1327.
    Gebuhrer L, Betuel H, Lambert J, Freidel AC, Farre A.
    Hum Immunol; 1987 Mar 15; 18(3):235-45. PubMed ID: 2437088
    [Abstract] [Full Text] [Related]

  • 9. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T, Tsukamoto K, Hirayama K, Nishimura Y, Takenouchi T, Aizawa M, Sasazuki T.
    J Immunol; 1985 Aug 15; 135(2):1288-98. PubMed ID: 3159789
    [Abstract] [Full Text] [Related]

  • 10. Serologic and molecular studies of two kindreds expressing recombinant HLA DR1/DR2 haplotypes.
    Wisecarver J, Shepherd S, Beisel K, Rubocki R.
    Tissue Antigens; 1993 Mar 15; 41(3):148-54. PubMed ID: 7686308
    [Abstract] [Full Text] [Related]

  • 11. The immunological detection of a 21-OH deficiency mutation HLA supratype.
    Pollack MS, Keenan B, Christiansen FT, Cobain TJ, Dawkins RL, Clayton G.
    Am J Hum Genet; 1986 May 15; 38(5):688-98. PubMed ID: 3013005
    [Abstract] [Full Text] [Related]

  • 12. A supertypic HLA class II determinant shared by DR1 and DRw9, and crossreactive with DR2, defined by human monoclonal antibody.
    Kosinski S, Yang SY, Pistillo MP, Hämmerling U.
    Hum Immunol; 1988 Mar 15; 21(3):221-31. PubMed ID: 2453492
    [Abstract] [Full Text] [Related]

  • 13. Dissociation in expression of MB1/MT1 and DR1 alloantigens in mutants of a lymphoblastoid cell line.
    DeMars R, Chang CC, Marrari M, Duquesnoy RJ, Noreen H, Segall M, Bach FH.
    J Immunol; 1983 Sep 15; 131(3):1318-21. PubMed ID: 6411812
    [Abstract] [Full Text] [Related]

  • 14. Antigen-specific human T-lymphocyte clones. Genetic restriction of influenza virus-specific responses to HLA-D region genes.
    Eckels DD, Lamb JR, Lake P, Woody JN, Johnson AH, Hartzman RJ.
    Hum Immunol; 1982 Jul 15; 4(4):313-24. PubMed ID: 6181037
    [Abstract] [Full Text] [Related]

  • 15. Molecular characterization by high-resolution isoelectric focusing of the products encoded by the class II region loci of the major histocompatibility complex in humans. I. DR and DQ gene variants.
    Rodriguez de Cordoba S, Nunez-Roldan A, Winchester R, Marshall P, Carrier C, Mollen N, Walker M, Ginsberg-Fellner F, Rubinstein P.
    Hum Immunol; 1987 Sep 15; 20(1):71-93. PubMed ID: 3679903
    [Abstract] [Full Text] [Related]

  • 16. Late-onset type of 21-hydroxylase deficiency in childhood.
    Roitman A, Stivel M, Zamir R, Kaufman H, Pertzelan A, Laron Z.
    Isr J Med Sci; 1982 Jul 15; 18(7):763-8. PubMed ID: 6980865
    [Abstract] [Full Text] [Related]

  • 17. Influenza A hemagglutinin-specific T cell clones strictly restricted by HLA-DR1 or HLA-DR7 molecules.
    Sterkers G, Henin Y, Lepage V, Fradelizzi D, Hannoun C, Levy JP.
    Eur J Immunol; 1984 Feb 15; 14(2):125-32. PubMed ID: 6199211
    [Abstract] [Full Text] [Related]

  • 18. Intra-HLA recombinations localizing the 21-hydroxylase deficiency gene within the HLA complex.
    Bias WB, Urban MD, Migeon CJ, Hsu SH, Lee PA.
    Hum Immunol; 1981 Mar 15; 2(2):139-45. PubMed ID: 6266985
    [Abstract] [Full Text] [Related]

  • 19. A family with an apparent HLA-DR triplet: evidence for exchange of functional HLA-DR beta-genes between different haplotypes.
    Tilanus MG, van Eggermond MC, Fei HM, Schreuder GM, Giphart MJ.
    Exp Clin Immunogenet; 1989 Mar 15; 6(2):162-8. PubMed ID: 2576521
    [Abstract] [Full Text] [Related]

  • 20. Major histocompatibility restriction of antigen recognition by T cells in a recipient of haplotype mismatched human bone marrow transplantation.
    Chu E, Umetsu D, Rosen F, Geha RS.
    J Clin Invest; 1983 Sep 15; 72(3):1124-9. PubMed ID: 6193142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.